Jan Zanger - Search Results

Year	Number of Results
1962	1
1971	1
1980	1
1982	1
1983	1
1989	1
1990	3
1991	2
1992	1
1995	2
1996	5
1997	2
2000	2
2001	2
2002	2
2003	6
2004	6
2005	3
2006	2
2007	3
2008	2
2009	2
2010	5
2011	7
2012	7
2013	10
2014	2
2015	12
2016	4
2017	4
2018	6
2019	4
2020	3
2021	4
2022	2
2024	1

1

Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.

Zanger UM, Schwab M. Zanger UM, et al. Pharmacol Ther. 2013 Apr;138(1):103-41. doi: 10.1016/j.pharmthera.2012.12.007. Epub 2013 Jan 16. Pharmacol Ther. 2013. PMID: 23333322 Free article. Review.

2

Epigenetics and MicroRNAs in Pharmacogenetics.

Zanger UM, Klein K, Kugler N, Petrikat T, Ryu CS. Zanger UM, et al. Adv Pharmacol. 2018;83:33-64. doi: 10.1016/bs.apha.2018.02.003. Epub 2018 Apr 23. Adv Pharmacol. 2018. PMID: 29801581 Review.

3

Omics and drug response.

Meyer UA, Zanger UM, Schwab M. Meyer UA, et al. Annu Rev Pharmacol Toxicol. 2013;53:475-502. doi: 10.1146/annurev-pharmtox-010510-100502. Epub 2012 Nov 5. Annu Rev Pharmacol Toxicol. 2013. PMID: 23140244 Review.

4

Editorial: Role of Protein-Protein Interactions in Metabolism: Genetics, Structure, Function.

Pandey AV, Henderson CJ, Ishii Y, Kranendonk M, Backes WL, Zanger UM. Pandey AV, et al. Front Pharmacol. 2017 Nov 27;8:881. doi: 10.3389/fphar.2017.00881. eCollection 2017. Front Pharmacol. 2017. PMID: 29230176 Free PMC article. No abstract available.

5

Overview of Development and Formulation of ¹⁷⁷Lu-DOTA-TATE for PRRT.

Breeman WA, Chan HS, de Zanger RM, Konijnenberg MK, de Blois E. Breeman WA, et al. Curr Radiopharm. 2016;9(1):8-18. doi: 10.2174/1874471008666150313111131. Curr Radiopharm. 2016. PMID: 25771369 Review.

6

Cytochrome P450 2B6: function, genetics, and clinical relevance.

Turpeinen M, Zanger UM. Turpeinen M, et al. Drug Metabol Drug Interact. 2012;27(4):185-97. doi: 10.1515/dmdi-2012-0027. Drug Metabol Drug Interact. 2012. PMID: 23152403 Review.

7

Role of ABC transporters in fluoropyrimidine-based chemotherapy response.

Nies AT, Magdy T, Schwab M, Zanger UM. Nies AT, et al. Adv Cancer Res. 2015;125:217-43. doi: 10.1016/bs.acr.2014.10.007. Epub 2015 Jan 8. Adv Cancer Res. 2015. PMID: 25640272 Review.

8

The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms.

Meyer UA, Skoda RC, Zanger UM. Meyer UA, et al. Pharmacol Ther. 1990;46(2):297-308. doi: 10.1016/0163-7258(90)90096-k. Pharmacol Ther. 1990. PMID: 2181495 Review.

9

Pharmacogenetics of anti-HIV drugs.

Telenti A, Zanger UM. Telenti A, et al. Annu Rev Pharmacol Toxicol. 2008;48:227-56. doi: 10.1146/annurev.pharmtox.48.113006.094753. Annu Rev Pharmacol Toxicol. 2008. PMID: 17883329 Review.

10

Molecular mechanisms of genetic polymorphisms of drug metabolism.

Meyer UA, Zanger UM. Meyer UA, et al. Annu Rev Pharmacol Toxicol. 1997;37:269-96. doi: 10.1146/annurev.pharmtox.37.1.269. Annu Rev Pharmacol Toxicol. 1997. PMID: 9131254 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

110 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year